Added to YB: 2026-01-14
Pitch date: 2026-01-10
TEM [bullish]
Tempus AI, Inc.
-38.97%
current return
Author Info
No bio for this author
Company Info
Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician’s desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests.
Market Cap
$8.4B
Pitch Price
$75.34
Price Target
150.00 (+249%)
Dividend
N/A
EV/EBITDA
-57.12
P/E
-33.40
EV/Sales
7.05
Sector
Life Sciences Tools and Services
Category
growth
Tempus AI- $TEM: Building the Foundational Data Platform for AI Driven Medicine
TEM: Precision medicine platform w/ 400 petabytes multimodal data from 40M+ patients. Q3 rev $334M (+85% YoY), targeting $1.3B 2025 (+80% YoY). First adj EBITDA+ quarter, path to GAAP profitability 2026-27. Bull case: data flywheel, pharma partnerships, regulatory wins. Bear: reimbursement risk, dilution from converts. DCF: $95 fair value vs ~$68 current. Strong platform compounding story if patient w/ volatility.
Read full article (12 min)